It has been found that in vitro and xenograft mouse models transfected with human-derived anti-IL-13Rα2 CAR and murine anti-IL-13Rα2 CAR human-derived CAR-T cells have better amplification ability and more effectively inhibit the growth of GBM tumor cells [77]. This evidence concerns the gene IL13RA2 and glioblastoma.